For Media Inquiries:
Purchaser Business Group on Health is working closely with its members to provide the deep expertise they need to navigate the health, market, policy and legal implications associated with the Supreme Court’s recent ruling on Roe v. Wade.
Gilbert will heighten PBGH’s strategic reach and influence as its members face constant challenges and competitive threats, a demanding economic climate and the complexities of health and health care reforms.
Health care industry provided their insights and predictions on the impact the pandemic is having on the explosion of virtual health options, changes to employee health benefits, what the future holds for our industry and how to better deliver value in health care.
In his first State of the Union address last night, President Biden called on Congress to pass legislation to lower the cost of prescription drug costs.
PBGH joined more than 90 organizations representing patients, consumers, seniors, unions, small businesses, large employers, physicians and disease advocacy groups to urge the Senate to immediately advance a reconciliation package that includes the reforms to lower prescription drug prices agreed to in the Build Back Better Act.
The Purchaser Business Group on Health calls on Congress to continue efforts to rein in drug prices, despite Sunday’s announcement by Sen. Joe Manchin III (D-W.Va.) that he could not support President Biden’s Build Back Better Act, which included provisions to protect the American people from high prescription drug costs.
The Purchaser Business Group on Health (PBGH) commends Sen. Mike Braun (R-IN) and Sen. Tammy Baldwin (D-WI) for introducing the Healthy Competition for Better Care Act.
The Employers’s Prescription for Affordable Drugs (EmployersRx) coalition applauds the work of congressional leaders to reach agreement regarding prescription drug provisions to be included in the Build Back Better Act.
The Purchaser Business Group on Health (PBGH) commends congressional negotiators who struck a landmark deal to reform the prescription drug market.
The Purchaser Business Group on Health is profoundly disappointed that the budget reconciliation framework announced today by President Biden omits any policies to deal with unaffordable prescription drugs.